Insider Trading Alert - OXFD, CSWC And CVS Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, June 2, 2015, 108 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $118.41 to $55,354,995.00.

Highlighted Stocks Traded by Insiders:

Oxford Immunotec Global (OXFD) - FREE Research Report

Sandberg Richard A, who is Director at Oxford Immunotec Global, sold 3,000 shares at $14.14 on June 2, 2015. Following this transaction, the Director owned 45,174 shares meaning that the stake was reduced by 6.23% with the 3,000-share transaction.

The shares most recently traded at $14.35, up $0.21, or 1.48% since the insider transaction. Historical insider transactions for Oxford Immunotec Global go as follows:

  • 4-Week # shares sold: 53,415
  • 12-Week # shares sold: 207,734
  • 24-Week # shares sold: 210,734

The average volume for Oxford Immunotec Global has been 49,800 shares per day over the past 30 days. Oxford Immunotec Global has a market cap of $320.8 million and is part of the health care sector and drugs industry. Shares are up 4.63% year-to-date as of the close of trading on Tuesday.

Oxford Immunotec Global PLC, a diagnostics company, develops and commercializes proprietary tests for the management of immune-regulated conditions in the United States, Europe, Japan, and China. Currently, there are 4 analysts who rate Oxford Immunotec Global a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on OXFD - FREE

TheStreet Quant Ratings rates Oxford Immunotec Global as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full Oxford Immunotec Global Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Insider Trading Alert - ZOES, OXFD And LFUS Traded By Insiders

Insider Trading Alert - PBIP, APOL And OXFD Traded By Insiders

Insider Trading Alert - OXFD, CSWC And CVS Traded By Insiders

Insider Trading Alert - OXFD, VLGEA And GLP Traded By Insiders